Page last updated: 2024-11-12
1,3-distearoyl-2-oleoylglycerol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 13183956 |
| SCHEMBL ID | 637876 |
| MeSH ID | M0301424 |
Synonyms (40)
| Synonym |
|---|
| 2-oleoyldistearin |
| 1,3-distearoyl-2-oleoylglycerol |
| 2-((1-oxooctadecyl)oxy)-1-(((1-oxooctadecyl)oxy)methyl)ethyl oleate |
| 2-((1-oxooctadecyl)oxy)-1-(((1-oxooctadecyl)oxy)methyl)ethyl 9-octadecenoate, (z)- |
| unii-4ke1y9738s |
| 9-octadecenoic acid (z)-, 2-((1-oxooctadecyl)oxy)-1-(((1-oxooctadecyl)oxy)methyl)ethyl ester |
| 4ke1y9738s , |
| 1,3-distearo-2-olein |
| 2846-04-0 |
| glyceryl 1,3-distearate-2-oleate |
| 2-oeoyl-1,3-distearin |
| olein, 1,3-distearo-2- |
| 2-oleo-1,3-distearin |
| 1,3-distearoyl-2-olein |
| einecs 220-643-2 |
| 2-oleoyl-1,3-distearoylglycerol |
| triglyceride stost,sn |
| 9-octadecenoic acid (9z)-, 2-((1-oxooctadecyl)oxy)-1-(((1-oxooctadecyl)oxy)methyl)ethyl ester |
| glyceryl 2-oleoyl-1,3-distearate |
| 1,3-di-o-stearoyl-2-o-oleoylglycerol |
| SCHEMBL637876 |
| tg(18:0/18:1(9z)/18:0) |
| 1-octadecanoyl-2-(9z-octadecenoyl)-3-octadecanoyl-glycerol |
| 1-stearoyl-2-oleoyl-3-stearoyl-glycerol |
| 1 3-distearoyl-2-oleoylglycerol |
| 2-(oleoyloxy)propane-1,3-diyl distearate |
| 1,3-distearoyl-2-oleoyl-glycerol |
| 1,3-distearoyl-2-oleoyl glycerol |
| [3-octadecanoyloxy-2-[(z)-octadec-9-enoyl]oxypropyl] octadecanoate |
| 1,3-stearin-2-olein |
| sos-pop beta1 |
| (1,3-distearoyl-2-oleoylglycerol) (1,3-dipalmitoyl-2-oleoylglycerol) |
| sos-beta-1 |
| Q27259880 |
| DTXSID301304181 |
| CAA84604 |
| PD120034 |
| 1,3-distearoyl-2-oleoyl-rac-glycerol |
| AKOS040756386 |
| BP-29832 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Pathways (2)
| Pathway | Proteins | Compounds |
|---|---|---|
| Triacylglycerol Degradation TG(18:0/18:1(9Z)/18:0) | 5 | 12 |
| De Novo Triacylglycerol Biosynthesis TG(18:0/18:1(9Z)/18:0) | 5 | 13 |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 17.72
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.72) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||